Page last updated: 2024-08-21

metylperon and Mental Disorders

metylperon has been researched along with Mental Disorders in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19903 (60.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bobo, WV; Jayathilake, K; Lee, MA; Meltzer, HY1
Delius-Stute, H; Kurz, A; Rettig, K; Schwalen, S1
Christensen, I; Geismar, L; Kirkegaard, A; Kirkegaard, G1
Hertrich, O1
Bakke, K; Brudvik, E; Elgen, K; Lien, GK; Moe, TJ; Nygaard, H1

Trials

2 trial(s) available for metylperon and Mental Disorders

ArticleYear
Melperone, an aytpical antipsychotic drug with clozapine-like effect on plasma prolactin: contrast with typical neuroleptics.
    Human psychopharmacology, 2009, Volume: 24, Issue:5

    Topics: Adult; Antipsychotic Agents; Butyrophenones; Clozapine; Female; Humans; Male; Mental Disorders; Prolactin; Sex Factors

2009
Zuclopenthixol and melperon in the treatment of elderly patients: a double-blind, controlled, multi-centre study.
    Pharmatherapeutica, 1988, Volume: 5, Issue:3

    Topics: Aged; Aged, 80 and over; Aggression; Antipsychotic Agents; Butyrophenones; Clinical Trials as Topic; Clopenthixol; Double-Blind Method; Female; Hostility; Humans; Male; Mental Disorders; Psychomotor Agitation; Random Allocation; Thioxanthenes

1988

Other Studies

3 other study(ies) available for metylperon and Mental Disorders

ArticleYear
[Treatment of behavioral disorders in dementia with risperidone in psychogeriatric out-patients].
    MMW Fortschritte der Medizin, 2003, Oct-09, Volume: 145 Suppl 3

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Ambulatory Care; Antipsychotic Agents; Butyrophenones; Clinical Trials as Topic; Dementia, Vascular; Dose-Response Relationship, Drug; Female; Humans; Male; Mental Disorders; Multicenter Studies as Topic; Prospective Studies; Risperidone; Treatment Outcome

2003
Additional studies on side effects of melperone in long-term therapy for 1 to 15 years in psychiatric patients.
    Arzneimittel-Forschung, 1981, Volume: 31, Issue:4

    Topics: Adult; Aged; Antipsychotic Agents; Butyrophenones; Dyskinesia, Drug-Induced; Electrocardiography; Eye Manifestations; Female; Humans; Male; Mental Disorders; Middle Aged; Salivation

1981
[Ataractic treatment in psychiatry and general medicine. Drug overview 10].
    Fortschritte der Medizin, 1983, Nov-17, Volume: 101, Issue:43

    Topics: Antipsychotic Agents; Butyrophenones; Humans; Mental Disorders; Mephenesin; Meprobamate; Mianserin; Tranquilizing Agents

1983